2006
Hoffrogge R., Beyer S., Völker U., Uhrmacher A., Rolfs A. (2006):
2-DE proteomic profiling of neuronal stem cells.
Neurodegenerative Dis 2006, 3(1-2): 112-120
Hoffrogge R., Mikkat S., Scharf C., Beyer S., Christoph H., Pahnke J., Mix E., Berth M., Uhrmacher A., Zubrzycki I., Miljan E., Völker U., Rolfs A. (2006):
2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM).
Proteomics 6: 1833-1847
Lange C, Mix E, Rateitschak K, Rolfs A (2006):
Wnt Signal Pathways and Neural Stem Cell Differentiation.
Neurodegenerative Dis 2006; 3: 76–86
Mix E, Goertsches R, Zett UK (2006):
Immunoglobulins - basic considerations.
J. Neurol. 253 (Suppl 5): v9-v17
Zou LP, Zhang WH, Wang HM, Zen M, Chen K, Mix E. (2006):
Maternal IgG suppresses NMDA-induced spasms in infant rats and inhibits NMDA-mediated neurotoxicity in hippocampal neurons.
J. Neuroimmunol. 181: 106-111
Zou LP, Ding CH, Fang F, Sin NC, Mix E. (2006):
Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms.
Clin. Neuropharmacol. 29: 343-349
Mix E, Ibrahim SM, Pahnke J, Glass A, Mazon-Pelaez I, Lemcke S, Koczan D, Gimsa U, Bansemer S, Scheel T, Karopka T, Bottcher T, Muller J, Dazert E, Antipova V, Hoffrogge R, Wree A, Zschiesche M, Strauss U, Kundt G, Warzok R, Gierl L, Rolfs A. (2006):
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.
J. Autoimmun. 27: 251-265